Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion

Author(s) Division of Cardiology, Ulsan Medical Center, Ulsan Hospital, Ulsan, South Korea.; Liew Houng Bang; Eun Jung Jun; Ae-Young Her; Ju-Hyun Chung; Garg, Scot; Joo Myung Lee; Joon-Hyung Doh; Chang-Wook Nam; Bon-Kwon Koo; Qiang Tang
Source Cardiology Journal; Jul 2021; vol. 28 (no. 4); p. 615-622
AbstractAlthough drug-eluting stents (DES) have become the mainstay of percutaneous coronary intervention, late and very late stent thrombosis remains a concern. Drug-coated balloons (DCB) have the advantage of preserving the anti-restenotic benefits of DES while minimizing potential long-term safety concerns. Currently the two methods to ensure successful DCB treatment of a stenotic lesion are angiography or physiology-guided DCB application. This review will evaluate these two methods based on previous evidence and make suggestions on how to perform DCB treatment more efficiently and safely.

• Available at Cardiology Journal from EBSCO (MEDLINE Complete)